Novocure Ltd
Abierto
SectorSanidad
17.56 -1.24
Resumen
Variación precio
24h
Mínimo
17.43
Máximo
18.27
Ingresos | -47M -71M |
|---|---|
Ventas | -295K 174M |
BPA | -0.62 |
Margen de beneficios | -40.871 |
Empleados | 1,605 |
EBITDA | -29M -63M |
Recomendaciones | Comprar |
|---|---|
Estimación a 12 Meses | +46.23% upside |
Próximas Ganancias | 23 jul 2026 |
|---|
Capitalización Mercado | 506M 2B |
|---|---|
Apertura anterior | 18.8 |
Cierre anterior | 17.56 |
Noticias sobre sentimiento de mercado
By Acuity
50%
50%
146 / 342 Clasificación en Healthcare
Novocure Ltd Gráfico
Resultados pasados no son un indicador fiable de resultados futuros.
Acerca de Novocure Ltd
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.